Hypermethylation of HOPX-β has been reported to be associated with poor survival in patients with differentiated thyroid cancer, and the methylation level of the HOPX promoter in esophageal squamous carcinoma tissue was inversely correlated with patient survival[53, 54]. Here, HOPX is linked to differentiated thyroid carcinoma.